Biofrontera Inc (NAS:BFRI)
$ 1.28 0 (0%) Market Cap: 7.10 Mil Enterprise Value: 4.15 Mil PE Ratio: 0 PB Ratio: 0.60 GF Score: 30/100

Biofrontera Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript

Feb 21, 2023 / 03:00PM GMT
Release Date Price: $16.07 (-1.93%)
Operator

Good day, ladies and gentlemen. Welcome to this 3rd Annual Winter Wonderland Best Ideas Virtual Investor Conference. The next presenting company is Biofrontera Inc. (Operator Instructions)

I'd now like to turn the floor over to your host for today's conference, Ms. Erica Monaco and Fred Leffler. The floor is yours.

Erica Monaco
Biofrontera Inc. - CEO

Thank you, and good morning, everyone. Thanks for joining us today at the Microcap Rodeo Conference. We're excited to be here today. It's myself and Fred Leffler, our CFO. I'm trying to dance the slides. I apologize. It looks like there's a brief delay on my side.

But just to jump right in, to give you a little bit about the company. So Biofrontera Inc. is a biopharmaceutical company. We specialize in the dermatology space. We have two products with tremendous market opportunity here in the US. Our lead therapy is Ameluz-PDT. PDT stands for photodynamic therapy. So this is a light treatment that is performed in the doctor's office.

As I mentioned, tremendous market opportunity for this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot